MyFinsight
Home
Blog
About
Contact
Download
Download image
Net loss available
to common...
-$5,533K
Net (loss) income
-$3,409K
Dividends on series c
preferred stock
$2,124K
(loss) income before
income tax expense
-$3,390K
Income tax expense
$19K
Interest and dividend
income
$1,921K
Operating loss
-$5,311K
Total operating
expenses
$5,311K
Transaction expenses
$3,955K
General and
administrative
$1,356K
Back
Back
Income Statement
source: myfinsight.com
ENZON PHARMACEUTICALS, INC. (ENZN)
ENZON PHARMACEUTICALS, INC. (ENZN)